¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Core Binding Factor alpha Subunits"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
amplification factor
ÁõÆøÀÎÀÚ
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
coagulation factor
ÀÀ°íÀÎÀÚ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
1. ¸é¿ª°¡´ÉÀÎÀÚ 2. ¹ÝÀÀ°¡´ÉÀÎÀÚ
competence inducing factor
¸é¿ª°¡´ÉÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
carcinogenic factor
¹ß¾ÏÀÎÀÚ
corticotropin-releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
chemotactic factor
ÈÇнò¸²ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
chemotactic factor
ÈÇÐÁÖ¼ºÀÎÀÚ, ÈÇнò¸²ÀÎÀÚ
coagulation factor
ÀÀ°íÀÎÀÚ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
Àû°ÝÀÎÀÚ
competence inducing factor
Àû°ÝÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ, Èñ¼®ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
alpha-2-macroglobulin
¾ËÆÄ-2-¸¶Å©·Î±Û·ÎºÒ¸°
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic agonist
¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
alpha-adrenergic antagonist
¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
alpha-amino acid nitrogen
¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
alpha-chain disease
¾ËÆÄ¼â Áúȯ(¡áð òðü´)
alpha-chymotrypsin
¾ËÆÄÄ«ÀÌ¸ðÆ®¸³½Å
alpha-fetoprotein
¾ËÆÄžƴܹé
alpha-fetoprotein
¾ËÆÄ-žƴܹé(¡÷Ãä®Ó±ÛÜ)
alpha-fucosidase
¾ËÆÄ-ǪÄڽôÙÁ¦(¡ð¥)
alpha-ketoglutarate
¾ËÆÄ-ÄÉÅä±Û·çŸ·¹ÀÌÆ®
alpha-l-iduronidase
a-L-Iduronidase
alpha-lipoproteinemia
¾ËÆÄ-Áö¹æ´Ü¹éÇ÷Áõ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
protein binding
´Ü¹éÁú °áÇÕ
protein,actin-binding
¾×ƾ-°áÇÕ(´Ü¹é)
receptor binding
¼ö¿ëü°áÇÕ
retinol-binding protein
·¹Æ¼³î°áÇմܹé(Áú)(·¹Æ¼³î Ì¿ùêÓ±ÛÜòõ)
sex hormone-binding globulin
¼ºÈ£¸£¸ó°áÇÕ±Û·Îºí¸°
sex-hormone binding globulin
testosterone-binding globulin
Å×½ºÅ佺Å×·Ð °áÇմܹé
thyroid-binding globulin
thyroxin binding globulin
Ƽ·Ï½Å°áÇձ۷κҸ°.
thyroxin binding prealbumin
Ƽ·Ï½Å°áÇÕÇÁ¸®¾ËºÎ¹Î.
thyroxin binding protein
Ƽ·Ï½Å°áÇմܹéÁú(¡Ì¿ùêÓ±ÛÜòõ).
thyroxine -binding globulin
Ƽ·Ï½Å°áÇÕ±Û·Îºí¸°
thyroxine-binding prealbumin
Ƽ·Ï½Å°áÇÕÇÁ¸®¾ËºÎ¹Î
total iron binding capacity
ÃÑö°áÇÕ´É
total iron binding capacity=TIBC
ÃÑö°áÇÕ´É
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½